Indian Pharma Soars with Record US Generic Drug Profits
Indian pharmaceutical companies are reporting exceptional earnings driven by US generic drug sales, leading to major fundraising initiatives for expansion into medtech and wellness sectors.
Category : Search result: pharma earnings
AstraZeneca Q3 Profit Jumps 77% to $2.53 Billion
British-Swedish pharma giant AstraZeneca reports blockbuster Q3 results with profits surging 77% to $2.53 billion, driven by robust cancer drug sales and strategic US market expansion.
Piramal Pharma Bets on US Biopharma Funding Revival
Piramal Pharma anticipates significant growth as US biopharma funding shows recovery signs, with CDMO business poised for major expansion.
Q2 FY2025 Earnings Beat Estimates: Metals, OMCs Lead
Kotak Securities report reveals stellar Q2 FY2025 results with metals and OMCs leading earnings beat. Discover which sectors exceeded estimates and the outlook for Indian markets.
LIC, Ola Electric, Lupin Q2 Results Today
Investors brace for a high-stakes earnings Thursday as insurance giant LIC, EV pioneer Ola Electric, and pharma major Lupin headline over 20 companies declaring Q2 FY2025 results. Get expert insights on what to expect.
Solara Pharma Q2 Loss: ₹10 Crore Amid Challenges
Solara Active Pharma Sciences faces challenging quarter with ₹10 crore net loss despite revenue growth. Discover the operational challenges and management's recovery strategy.
Sun Pharma Q2 Profit Rises 2.5% to ₹3,118 Crore
India's pharmaceutical giant Sun Pharma reports steady Q2 growth with 9% revenue increase while navigating US market challenges. Key insights from their latest earnings report.
Navin Fluorine Shares Surge 22% in 3 Sessions
Discover why Navin Fluorine International shares skyrocketed 22% in just three trading sessions. Expert analysis reveals the key drivers behind this chemical sector powerhouse's impressive rally and what investors should watch next.
Q2 Results Today: Sun Pharma, Grasim, Britannia Earnings
Market eyes Wednesday's Q2 earnings bonanza as pharma giant Sun Pharma, Grasim Industries, and FMCG major Britannia declare results. Get complete analysis and investor expectations.
Adani Q2 Profits Soar 130% Despite Coal Trade Dip
Adani Enterprises reports stellar Q2 performance with 130% profit surge to ₹228 crore, driven by airport operations and green hydrogen initiatives, while coal trading faces headwinds.
Route Mobile Q2: ₹19 Crore Loss, Revenue Growth Stalls
CPaaS leader Route Mobile faces surprising Q2 setback with ₹19 crore loss versus last year's profit. Revenue growth stalls at 0.7% amid global economic pressures. Discover what went wrong.
3 Hot Stocks: Grasim, Aurobindo Pharma, City Union Bank
Religare Broking's Ajit Mishra reveals 3 promising stocks for short-term gains. Discover technical analysis and price targets for Grasim, Aurobindo Pharma, and City Union Bank in this exclusive market insight.
SBI, Adani Enterprises, Paytm Q2 Results Today - Stocks to Watch
Stock market braces for earnings tsunami as State Bank of India, Adani Enterprises, Mahindra & Mahindra, and Paytm parent One 97 Communications lead today's Q2 results declaration. Get complete analysis and market expectations.
Hot Stocks: Oil India, Aurobindo Pharma, Latent View Analysis
Get expert stock market insights from Jigar Patel of Anand Rathi as he reveals why Oil India, Aurobindo Pharma, and Latent View Analytics present compelling short-term opportunities for Indian investors.
Q2 Results: Bharti Airtel, Titan, Power Grid Earnings Today
Major Indian companies including Bharti Airtel, Titan Company, and Power Grid Corporation are set to declare their Q2 FY2025 earnings today. Get insights into market expectations, key metrics to watch, and how these results could impact your investment de
Wall Street Eyes Q3 Earnings Amid Record Government Shutdown
As the US government shutdown extends to record length, Wall Street shifts focus to Q3 corporate earnings. Discover how this political stalemate impacts market sentiment and investor strategy.
Q2 Earnings: Airtel, SBI, LIC, Paytm, Adani Results Next Week
Get ready for a blockbuster week in Indian markets as corporate giants including Bharti Airtel, SBI, LIC, Paytm, and Adani Enterprises declare their Q2 FY2025 results. Discover key expectations and market-moving insights.
Q2 Results 2025: Urban Company, Tata Chemicals Among 27 Earnings
Stock market investors brace for major Q2 earnings announcements as Urban Company, Tata Chemicals and 25 other companies set to reveal financial performance today. Get complete list and analysis.
Health Biotech Expands Global Presence at CPhI Frankfurt
Indian biopharmaceutical leader Health Biotech Limited makes waves at CPhI Frankfurt 2025, showcasing innovative products and forging international partnerships to strengthen its global market position.
Niner Pharma Expands R&D with 125 New Peptide Molecules
Chandigarh-based Niner Pharma announces massive R&D expansion with 125 novel peptide molecules targeting wellness and cosmetic innovation, positioning India as global leader in peptide research.
Q2 Results: Maruti, Vedanta, BPCL, GAIL, BEL Earnings
Major Indian companies including Maruti Suzuki, Vedanta, BEL, BPCL, and GAIL are announcing their Q2 FY2025 earnings today. Get insights on expected performance, key financial indicators, and market impact analysis.
Apple Hits ₹8.5L Cr Revenue as iPhone 17 Sales Soar
Apple's Q4 earnings reveal massive ₹8.5 lakh crore revenue and ₹2.3 lakh crore profit as iPhone 17 sales explode. Discover how India's premium smartphone market is fueling this historic growth.
Cipla Shares Fall 4% After Q2 Results
Cipla's stock faced significant pressure after Q2 FY2025 results revealed margin pressures despite revenue growth. Discover the key factors behind the 4% decline and what analysts are saying about the pharmaceutical giant's future prospects.
Q2 Results: ITC, Swiggy, NTPC, Adani Power Earnings Today
Major Indian companies including ITC, Swiggy, NTPC, and Adani Power declare Q2 earnings today. Get insights into market expectations and performance analysis.
Google's AI Boom Fuels Record $102B Q3 Revenue
Alphabet's Q3 2024 earnings smash expectations as artificial intelligence drives unprecedented growth across Google's advertising and cloud divisions, marking a stunning tech comeback.
Meta Profits Crash 52% on $16B Trump Tax Charge
Meta Platforms reports staggering 52% profit decline in Q3 earnings, hit by massive $16 billion legal charge from Trump administration legislation. Revenue growth continues despite Reality Labs losses.
US Push for Affordable Biotech Drugs: India's Opportunity
Federal health officials are accelerating efforts to bring cheaper biotech drugs to market, potentially transforming treatment access and creating new opportunities for Indian pharmaceutical companies.
India Bans Fraudulent Pharma Licenses in Major Reform
India implements sweeping regulatory reforms to combat fraudulent pharmaceutical manufacturing licenses, enhancing drug safety standards for domestic and international markets including US and EU.
Coal India Q2 profit plunges 32% due to heavy rains
Coal India reports significant 32% drop in Q2 net profit amid production challenges caused by excessive rainfall. Revenue declines 3% as operations face weather-related hurdles.
Q2 Results: L&T, HPCL, RailTel, Coal India Earnings Today
Major Indian companies including L&T, HPCL, RailTel, and Coal India set to announce Q2 FY2025 earnings today. Get insights on market expectations and sector performance in this comprehensive earnings analysis.
Page 1 of 4